Status:
COMPLETED
Optimized Peak VO2 in Predicting Advanced HF
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Heart Failure
Morality
Eligibility:
All Genders
20-90 years
Brief Summary
The ability and timely selection of severe heart failure (HF) patients for cardiac transplantation and advanced HF therapy is challenging. Peak VO2 by cardiopulmonary exercise test (CPET) was used for...
Detailed Description
Investigators retrospectively collected acute HF patients discharged alive from the hospital. Investigators divided participants into more-GDMT (≥2 kinds) and few-GDMT (\<2 kinds) groups and compared ...
Eligibility Criteria
Inclusion
- acute HF patients with reduced ejection fraction (left ventricular ejection fraction, LVEF \<=40%) and discharged alive from the hospital
- patients with age \>= 20 years of age
- patients who performed cardiopulmonary exercise test (CPET) within one month after discharge
- patients with serum B-type natriuretic peptide (BNP) level \>100 pg/mL.
Exclusion
- patients with estimated survival time \< 6 months
- patients who could not tolerate exercise test due to muscular-skeletal disorder or other reason
- patients who had severe valvular heart disease.
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
377 Patients enrolled
Trial Details
Trial ID
NCT05212649
Start Date
May 1 2014
End Date
July 30 2021
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital Heart Failure Center
Kaohsiung City, Taiwan, 83341